-
MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD
-
All Study Sites Open in Phase 3 Cross-Over Extension Study
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Study Site Opens for Phone Screening in Tel Hashomer, Israel
-
MDMA-Assisted Therapy for PTSD: An Update on the Progress of MAPS’ Pivotal Program
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
First Participant in Israel Enrolled in Phase 3 MDMA-Assisted Therapy Study in Israel
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Publication in Nature Medicine and Major Media Coverage
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD May 2021 Update: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
-
MAPS and MAPS Public Benefit Corporation Announce Positive Result from Phase 3 Trial of MDMA-Assisted Therapy for PTSD
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: All Experimental Treatment Sessions Completed in First Trial, Enrollment Continues in Second Trial
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Currently Enrolling
-
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: All Sites Enroll a Participant